Maxim Rosario, MBBChBAO, PhD
Pathology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Maxim Rosario
Primary Academic Title
Assistant Professor of Pathology
Johns Hopkins Physician
Background
Dr. Maxim Rosario is an assistant professor of pathology at the Johns Hopkins University School of Medicine. His clinical focus is on analyzing patient specimen samples for the development of immune pathology with most cases analyzed for suspected Multiple Myeloma. Clinical duties also include oversight of other tests requested by physicians. His research focus is on the study of NK cells and their use in immune therapy as it relates to cancer. He also studies CD8 T cell mediated immunity and its role in viral pathogenicity and vaccinology.
He received his undergraduate degree in Cell Biotechnology and a Master of Science in Microbiology from the University of Alberta, Edmonton, Canada. He earned his MB BCh BAO from University College Cork in Cork, Ireland and his DPhil in Vaccinology from the University of Oxford, Oxford, England. He completed a clinical pathology residency at Washington University School of Medicine in St. Louis, Missouri. Dr. Rosario joined the Johns Hopkins faculty in 2017.
Additional Academic Titles
Assistant Professor of Oncology
Research Interests
NK cells and their use in immune therapy
Google Scholar - Publications
https://scholar.google.com/citations?user=sPY7a98AAAAJ&hl=en&oi=sra
Selected Publications
Rosario M*, Liu B*, Kong L, Collins LI, Schneider SE, Chen X, Han K, Jeng EK, Rhode PR, Leong JW, Schappe T, Jewell BA, Keppel CR, Shah K, Hess B, Romee R, Piwnica-Worms DR, Cashen AF, Bartlett NL, Wong HC, Fehniger TA. The IL-15-based ALT-803 complex enhances FcγRIIIa-triggered NK cell responses and in vivo clearance of B cell lymphomas. Clin Cancer Res. 2016;22(3):596-608
Romee R*, Rosario M*, Berrien-Elliott M, Wagner JA, Jewell BA, Schappe T, Leong JW, Abdel-Latif S, Schneider SE, Willey S, Neal CC, Yu L, Oh ST, Lee Y, Mulder A, Claas F, Cooper MA, Fehniger TA. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med. 2016;8(357):357ra123
Wagner JA*, Rosario M*, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, Sullivan RP, Jewell BA, Becker-Hapak M, Schappe T, Abdel-Latif S, Ireland AR, Jaishankar D, King JA, Vij R, Clement D, Goodridge J, Malmberg KJ, Wong HC, Fehniger TA. CD56 bright NK cells exhibit potent antitumor responses following IL-15 priming. J Clin Invest. 2017;127(11):4042-58
Wagner JA, Berrien-Elliott MM, Rosario M, Leong JW, Jewell BA, Schappe T, Abdel-Latif S, Fehniger TA. Cytokine-induced memory-like differentiation enhances unlicensed natural killer cell antileukemia and FcγRIIIa-triggered responses. Biol Blood Marrow Transplant. 2017;23(3):398-404
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- Get Directions
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
- Fellowship: UCLA Medical Center, Clinical Immunogenetics, 2017
- Residency: Barnes-Jewish Health, Clinical Pathology, 2015
- Fellowship: University of Alberta Hospital, Microbiology & Immunology, 2012
- Graduate School: University of Oxford School of Medicine, PhD, 2010
- Residency: Cork University Hospital, General/Vascular Surgery, 2006
- Graduate School: University of Oxford School of Medicine, MSc, 2005
- Medical Education: University College Cork School of Medicine, MB BCh BAO, 2004
Board Certifications
- Clinical Pathology: American Board of Pathology, 2015
Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- Veteran Affairs Community Care Network (Optum-VACCN)